B and T cell immunity in MS with anti-CD20 therapy: Gene expression and protein profiles

被引:0
|
作者
Fong, C. [1 ]
Spencer, J. [1 ]
Howlett-Prieto, Q. [1 ]
Park, G. [1 ]
Feng, X. [1 ]
Reder, A. [1 ]
机构
[1] Univ Chicago, Neurol, Chicago, IL USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P614
引用
收藏
页码:535 / 535
页数:1
相关论文
共 50 条
  • [41] Effector mechanisms of anti-CD20 monoclonal antibodies in B cell malignancies
    Okroj, Marcin
    Osterborg, Anders
    Blom, Anna M.
    [J]. CANCER TREATMENT REVIEWS, 2013, 39 (06) : 632 - 639
  • [42] Rates and predictors of serious infections in MS and NMOSD patients treated with anti-CD20 therapy
    Mears, V.
    Jakubecz, C.
    Serra, A.
    Abboud, H.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 357 - 357
  • [43] Rates and Predictors of Serious Infections in MS and NMOSD Patients treated with Anti-CD20 Therapy
    Abboud, Hesham
    Mears, Veronica
    Jakubecz, Collin
    Serra, Alessandro
    [J]. NEUROLOGY, 2023, 100 (17)
  • [44] Effects of anti-CD20 therapy on circulating and intrathecal follicular helper T cell subsets in multiple sclerosis
    El Mahdaoui, Sahla
    Hansen, Marie Mathilde
    Hansen, Malene Bredahl
    Hvalkof, Victoria Hyslop
    Ondergaard, Helle Bach S.
    Mahler, Mie Reith
    Christensen, Jeppe Romme
    Sellebjerg, Finn
    von Essen, Marina Rode
    [J]. CLINICAL IMMUNOLOGY, 2024, 264
  • [45] Characterization of the B cell response to Leishmania infection after anti-CD20 B cell depletion
    Bockenstedt, Marie M.
    Boggiatto, Paola M.
    Jones, Douglas E.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (06): : 6192 - 6202
  • [46] Enhanced anti-B-cell tumor effects with anti-CD20 superantibody - Comments
    Reisfeld, RA
    [J]. JOURNAL OF IMMUNOTHERAPY, 2002, 25 (01): : 62 - 62
  • [47] Myelin-specific CD8+T cells in MS exhibit a unique activated phenotype and are depleted by anti-CD20 therapy
    Sabatino, J.
    Wilson, M.
    Calabresi, P.
    Hauser, S.
    Schneck, J.
    Zamvil, S.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 106 - 107
  • [48] B cell-targeted therapy with anti-CD20 monoclonal antibody in a mouse model of Graves' hyperthyroidism
    Ueki, I.
    Abiru, N.
    Kobayashi, M.
    Nakahara, M.
    Ichikawa, T.
    Eguchi, K.
    Nagayama, Y.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 163 (03): : 309 - 317
  • [49] Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma
    Heinzerling, L
    Dummer, R
    Kempf, W
    Schmid, MH
    Burg, G
    [J]. ARCHIVES OF DERMATOLOGY, 2000, 136 (03) : 374 - 378
  • [50] Anti-Tumor Effects of Anti-CD20 Chimeric Antigen Receptor Therapy in Canine B Cell Lymphoma Patients
    Panjwani, M. Kazim
    Gnanandarajah, Josephine S.
    MaloneyHuss, Martha A.
    Mason, Nicola J.
    [J]. MOLECULAR THERAPY, 2016, 24 : S296 - S296